KioMedineVSone
Implants, Prosthetics
Information
KioMedineVSone is a first-in-class, single-injection fluid implant developed by KiOmed Pharma for the symptomatic treatment of knee osteoarthritis (OA). It introduces a completely new therapeutic class based on Carboxymethyl-Chitosan (CM-Chitosan), a patented, animal-free polymer derived from Agaricus bisporus (button mushroom). This breakthrough innovation combines science, sustainability, and patient-centric care to address one of the largest unmet needs in knee refractory osteoarthritis management.
